Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Vera SemenovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
Garik SagoyanN.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, 115478 Moscow, Russia.ORCID 0000-0002-7846-3473
Elena ZhukovskayaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117198 Moscow, Russia.
Valentina KozlovaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, 115478 Moscow, Russia.
Nina GegeliaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117198 Moscow, Russia.
Anna MitrofanovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117198 Moscow, Russia.
Amina SuleymanovaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, 115478 Moscow, Russia.ORCID 0000-0002-5489-1879
Alexander DruyDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117198 Moscow, Russia.
Ekaterina ZelenovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-2197-8863
Vladislav PavlovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-2942-6393
Marina RubanskayN.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, 115478 Moscow, Russia.
Alexander KarelinDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117198 Moscow, Russia.
Svetlana VarfolomeevaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, 115478 Moscow, Russia.
Tatiana NasedkinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-2642-4202
Funding
Ministry of Health of the Russian Federation Clinical trial protocol #2019-55-6" Clinical application of methods for diagnosing the toxic effects of anticancer therapy and innovative technologies for habilitation/rehabilitation of patients with ex-tracranial embryonic tumors" (01.09.2020-31.12.2022)Program of Fundamental Research in the Russian Federation for the 2021-2030 project No. 124032100002-1
6 · The paper itself
Abstract
Wilms tumor (WT), the most common kidney neoplasm in children, is closely associated with hereditary factors. This study included 134 WT patients (62 males, median age of 7 years, age at diagnosis of 24.9 months) with unilateral (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Genetic and Epigenetic Drivers of Wilms Tumor Predisposition in Russian Pediatric Patients: A Multicenter Study. · full record | OpenQuestion